[ Price : $8.95]
Senator Ron Johnson (R-WI) launches a congressional investigation into FDAs recent decisions to reject or delay treatments for rar...[ Price : $8.95]
FDA launches its new Adverse Event Monitoring System to ultimately house all adverse events reported on FDA-regulated products on ...[ Price : $8.95]
FDA approves Bristol Myers Squibs Sotyktu (deucravacitinib), an oral therapy for treating adults with active psoriatic arthritis.[ Price : $8.95]
A Newsweek report details four major issues it says have plagued FDA in its first year under commissioner Marty Makary.[ Price : $8.95]
FDA releases the Form 483 behind a 3/5 Warning Letter to Novo Nordisk that cited serious violations of postmarketing adverse drug ...[ Price : $8.95]
FDA warns Indias Tentamus India Private Limited contract laboratory about significant violations of CGMP regulations.[ Price : $8.95]
FDA warns Exactech, doing business as Advita Ortho, about Quality System violations in its production of accessories for the Equin...[ Price : $8.95]
FDA posts a 3/5 complete response letter to Rosemont Pharmaceuticals, rejecting the companys NDA for valacyclovir.